{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T05:18:50Z","timestamp":1787894330912,"version":"build-2784847793"},"reference-count":154,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,27]]},"DOI":"10.7759\/cureus.115330","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T04:51:18Z","timestamp":1787892678000},"source":"Crossref","is-referenced-by-count":0,"title":["Reactive Oxygen Species in Cardiovascular and Hematological Diseases: Mechanisms and Therapeutic Strategies"],"prefix":"10.7759","author":[{"given":"Anthony","family":"Alanis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Cisneros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector","family":"Trejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsey","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2023.119573","article-title":"Reactive oxygen species and cell signaling. Review","volume":"1871","author":"Averill-Bates D","year":"2024","unstructured":"Averill-Bates D. Reactive oxygen species and cell signaling. Review. Biochim Biophys Acta Mol Cell Res. 2024, 1871:119573. 10.1016\/j.bbamcr.2023.119573","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/8563845","article-title":"Targeting early atherosclerosis: a focus on oxidative stress and inflammation","volume":"2019","author":"Marchio P","year":"2019","unstructured":"Marchio P, Guerra-Ojeda S, Vila JM, Aldasoro M, Victor VM, Mauricio MD. Targeting early atherosclerosis: a focus on oxidative stress and inflammation. Oxid Med Cell Longev. 2019, 2019:8563845. 10.1155\/2019\/8563845","journal-title":"Oxid Med Cell Longev"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10030602","article-title":"Reactive oxygen species induced pathways in heart failure pathogenesis and potential therapeutic strategies","volume":"10","author":"Mongirdien\u0117 A","year":"2022","unstructured":"Mongirdien\u0117 A, Skrodenis L, Varoneckait\u0117 L, Mierkyt\u0117 G, Gerulis J. Reactive oxygen species induced pathways in heart failure pathogenesis and potential therapeutic strategies. Biomedicines. 2022, 10:602. 10.3390\/biomedicines10030602","journal-title":"Biomedicines"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6043550","article-title":"The role of RIPC in preventing organ damage, inflammation, and oxidative stress during lower limb DSA: a randomised controlled trial","volume":"2021","author":"Kuusik K","year":"2021","unstructured":"Kuusik K, Kasepalu T, Zilmer M, et al.. The role of RIPC in preventing organ damage, inflammation, and oxidative stress during lower limb DSA: a randomised controlled trial. Oxid Med Cell Longev. 2021, 2021:6043550. 10.1155\/2021\/6043550","journal-title":"Oxid Med Cell Longev"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.831847","article-title":"The induction of endothelial autophagy and its role in the development of atherosclerosis","volume":"9","author":"Hua Y","year":"2022","unstructured":"Hua Y, Zhang J, Liu Q, et al.. The induction of endothelial autophagy and its role in the development of atherosclerosis. Front Cardiovasc Med. 2022, 9:831847. 10.3389\/fcvm.2022.831847","journal-title":"Front Cardiovasc Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000000801","article-title":"Hu antigen R is required for NOX-1 but not NOX-4 regulation by inflammatory stimuli in vascular smooth muscle cells","volume":"34","author":"Aguado A","year":"2016","unstructured":"Aguado A, Fischer T, Rodr\u00edguez C, et al.. Hu antigen R is required for NOX-1 but not NOX-4 regulation by inflammatory stimuli in vascular smooth muscle cells. J Hypertens. 2016, 34:253-65. 10.1097\/HJH.0000000000000801","journal-title":"J Hypertens"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1021\/acs.biochem.6b00703","article-title":"Excessive reactive oxygen species and exotic DNA lesions as an exploitable liability","volume":"55","author":"AbdulSalam SF","year":"2016","unstructured":"AbdulSalam SF, Thowfeik FS, Merino EJ. Excessive reactive oxygen species and exotic DNA lesions as an exploitable liability. Biochemistry. 2016, 55:5341-52. 10.1021\/acs.biochem.6b00703","journal-title":"Biochemistry"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M116.769455","article-title":"FOXO3 transcription factor is essential for protecting hematopoietic stem and progenitor cells from oxidative DNA damage","volume":"292","author":"Bigarella CL","year":"2017","unstructured":"Bigarella CL, Li J, Rimmel\u00e9 P, Liang R, Sobol RW, Ghaffari S. FOXO3 transcription factor is essential for protecting hematopoietic stem and progenitor cells from oxidative DNA damage. J Biol Chem. 2017, 292:3005-15. 10.1074\/jbc.M116.769455","journal-title":"J Biol Chem"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvp176","article-title":"Oxidative stress activates ADAM17\/TACE and induces its target receptor shedding in platelets in a p38-dependent fashion","volume":"84","author":"Brill A","year":"2009","unstructured":"Brill A, Chauhan AK, Canault M, Walsh MT, Bergmeier W, Wagner DD. Oxidative stress activates ADAM17\/TACE and induces its target receptor shedding in platelets in a p38-dependent fashion. Cardiovasc Res. 2009, 84:137-44. 10.1093\/cvr\/cvp176","journal-title":"Cardiovasc Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21249652","article-title":"Oxidative DNA damage, inflammatory signature, and altered erythrocytes properties in Diamond-Blackfan anemia","volume":"21","author":"Kapralova K","year":"2020","unstructured":"Kapralova K, Jahoda O, Koralkova P, et al.. Oxidative DNA damage, inflammatory signature, and altered erythrocytes properties in Diamond-Blackfan anemia. Int J Mol Sci. 2020, 21:9652. 10.3390\/ijms21249652","journal-title":"Int J Mol Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/9912436","article-title":"Reactive oxygen species (ROS) regulates different types of cell death by acting as a rheostat","volume":"2021","author":"Villalpando-Rodriguez GE","year":"2021","unstructured":"Villalpando-Rodriguez GE, Gibson SB. Reactive oxygen species (ROS) regulates different types of cell death by acting as a rheostat. Oxid Med Cell Longev. 2021, 2021:9912436. 10.1155\/2021\/9912436","journal-title":"Oxid Med Cell Longev"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/CRD.0000000000000727","article-title":"Nanotechnology: The future for diagnostic and therapeutic intervention in cardiovascular diseases is here","author":"Elsaygh J","year":"2024","unstructured":"Elsaygh J, Zaher A, Parikh MA, Frishman WH, Peterson SJ. Nanotechnology: The future for diagnostic and therapeutic intervention in cardiovascular diseases is here. Cardiol Rev. 2024, 10.1097\/CRD.0000000000000727","journal-title":"Cardiol Rev"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines8070206","article-title":"NADPH oxidases and their role in atherosclerosis","volume":"8","author":"Poznyak AV","year":"2020","unstructured":"Poznyak AV, Grechko AV, Orekhova VA, Khotina V, Ivanova EA, Orekhov AN. NADPH oxidases and their role in atherosclerosis. Biomedicines. 2020, 8:206. 10.3390\/biomedicines8070206","journal-title":"Biomedicines"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.120.313831","article-title":"Skeletal muscle pathology in peripheral artery disease: a brief review","volume":"40","author":"McDermott MM","year":"2020","unstructured":"McDermott MM, Ferrucci L, Gonzalez-Freire M, et al.. Skeletal muscle pathology in peripheral artery disease: a brief review. Arterioscler Thromb Vasc Biol. 2020, 40:2577-85. 10.1161\/ATVBAHA.120.313831","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.309326","article-title":"Roles of vascular oxidative stress and nitric oxide in the pathogenesis of atherosclerosis","volume":"120","author":"F\u00f6rstermann U","year":"2017","unstructured":"F\u00f6rstermann U, Xia N, Li H. Roles of vascular oxidative stress and nitric oxide in the pathogenesis of atherosclerosis. Circ Res. 2017, 120:713-35. 10.1161\/CIRCRESAHA.116.309326","journal-title":"Circ Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-017-0531-9","article-title":"Advanced glycation end-products decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells","volume":"16","author":"Ren X","year":"2017","unstructured":"Ren X, Ren L, Wei Q, Shao H, Chen L, Liu N. Advanced glycation end-products decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells. Cardiovasc Diabetol. 2017, 16:52. 10.1186\/s12933-017-0531-9","journal-title":"Cardiovasc Diabetol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/7092151","article-title":"Vascular inflammation and oxidative stress: major triggers for cardiovascular disease","volume":"2019","author":"Steven S","year":"2019","unstructured":"Steven S, Frenis K, Oelze M, et al.. Vascular inflammation and oxidative stress: major triggers for cardiovascular disease. Oxid Med Cell Longev. 2019, 2019:7092151. 10.1155\/2019\/7092151","journal-title":"Oxid Med Cell Longev"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2005.11.007","article-title":"Conceptualization and working definition of heart failure","volume":"12","author":"Heart Failure Society Of America","year":"2006","unstructured":"Heart Failure Society Of America. Conceptualization and working definition of heart failure. J Card Fail. 2006, 12:e10-1. 10.1016\/j.cardfail.2005.11.007","journal-title":"J Card Fail"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2021.01.022","article-title":"Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and writing committee of the universal definition of heart failure","volume":"27","author":"Bozkurt B","year":"2021","unstructured":"Bozkurt B, Coats AJ, Tsutsui H, et al.. Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and writing committee of the universal definition of heart failure. J Card Fail. 2021, 27:387-413. 10.1016\/j.cardfail.2021.01.022","journal-title":"J Card Fail"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2020.12.026","article-title":"Discovery of new therapeutic redox targets for cardioprotection against ischemia\/reperfusion injury and heart failure","volume":"163","author":"Daiber A","year":"2021","unstructured":"Daiber A, Andreadou I, Oelze M, Davidson SM, Hausenloy DJ. Discovery of new therapeutic redox targets for cardioprotection against ischemia\/reperfusion injury and heart failure. Free Radic Biol Med. 2021, 163:325-43. 10.1016\/j.freeradbiomed.2020.12.026","journal-title":"Free Radic Biol Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv305","article-title":"Pathophysiological role of oxidative stress in systolic and diastolic heart failure and its therapeutic implications","volume":"36","author":"M\u00fcnzel T","year":"2015","unstructured":"M\u00fcnzel T, Gori T, Keaney JF Jr, Maack C, Daiber A. Pathophysiological role of oxidative stress in systolic and diastolic heart failure and its therapeutic implications. Eur Heart J. 2015, 36:2555-64. 10.1093\/eurheartj\/ehv305","journal-title":"Eur Heart J"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1320","article-title":"Treating oxidative stress in heart failure: past, present and future","volume":"21","author":"van der Pol A","year":"2019","unstructured":"van der Pol A, van Gilst WH, Voors AA, van der Meer P. Treating oxidative stress in heart failure: past, present and future. Eur J Heart Fail. 2019, 21:425-35. 10.1002\/ejhf.1320","journal-title":"Eur J Heart Fail"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10060931","article-title":"Oxidative stress as a mechanism for functional alterations in cardiac hypertrophy and heart failure","volume":"10","author":"Shah AK","year":"2021","unstructured":"Shah AK, Bhullar SK, Elimban V, Dhalla NS. Oxidative stress as a mechanism for functional alterations in cardiac hypertrophy and heart failure. Antioxidants (Basel). 2021, 10:931. 10.3390\/antiox10060931","journal-title":"Antioxidants (Basel)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20133294","article-title":"Modulation of nitric oxide synthases by oxidized LDLs: role in vascular inflammation and atherosclerosis development","volume":"20","author":"Gliozzi M","year":"2019","unstructured":"Gliozzi M, Scicchitano M, Bosco F, et al.. Modulation of nitric oxide synthases by oxidized LDLs: role in vascular inflammation and atherosclerosis development. Int J Mol Sci. 2019, 20:3294. 10.3390\/ijms20133294","journal-title":"Int J Mol Sci"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00727.2014","article-title":"Impaired cardiac mitochondrial oxidative phosphorylation and enhanced mitochondrial oxidative stress in feline hypertrophic cardiomyopathy","volume":"308","author":"Christiansen LB","year":"2015","unstructured":"Christiansen LB, Dela F, Koch J, Hansen CN, Leifsson PS, Yokota T. Impaired cardiac mitochondrial oxidative phosphorylation and enhanced mitochondrial oxidative stress in feline hypertrophic cardiomyopathy. Am J Physiol Heart Circ Physiol. 2015, 308:H1237-47. 10.1152\/ajpheart.00727.2014","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-018-0082-x","article-title":"The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"16","author":"Kazankov K","year":"2019","unstructured":"Kazankov K, J\u00f8rgensen SM, Thomsen KL, et al.. The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Nat Rev Gastroenterol Hepatol. 2019, 16:145-59. 10.1038\/s41575-018-0082-x","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00036.2017","article-title":"Sources of vascular nitric oxide and reactive oxygen species and their regulation","volume":"99","author":"Tejero J","year":"2019","unstructured":"Tejero J, Shiva S, Gladwin MT. Sources of vascular nitric oxide and reactive oxygen species and their regulation. Physiol Rev. 2019, 99:311-79. 10.1152\/physrev.00036.2017","journal-title":"Physiol Rev"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(91)90382-u","article-title":"Coronary thrombosis: pathogenesis and clinical manifestations","volume":"68","author":"Falk E","year":"1991","unstructured":"Falk E. Coronary thrombosis: pathogenesis and clinical manifestations. Am J Cardiol. 1991, 68:28-35. 10.1016\/0002-9149(91)90382-u","journal-title":"Am J Cardiol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00617.2019","article-title":"MitoQ regulates redox-related noncoding RNAs to preserve mitochondrial network integrity in pressure-overload heart failure","volume":"318","author":"Kim S","year":"2020","unstructured":"Kim S, Song J, Ernst P, et al.. MitoQ regulates redox-related noncoding RNAs to preserve mitochondrial network integrity in pressure-overload heart failure. Am J Physiol Heart Circ Physiol. 2020, 318:H682-95. 10.1152\/ajpheart.00617.2019","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2019.101100","article-title":"Mitoquinone ameliorates pressure overload-induced cardiac fibrosis and left ventricular dysfunction in mice","volume":"21","author":"Goh KY","year":"2019","unstructured":"Goh KY, He L, Song J, et al.. Mitoquinone ameliorates pressure overload-induced cardiac fibrosis and left ventricular dysfunction in mice. Redox Biol. 2019, 21:101100. 10.1016\/j.redox.2019.101100","journal-title":"Redox Biol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2022.111812","article-title":"Increased levels of circulating oxidized mitochondrial DNA contribute to chronic inflammation in metabolic syndrome, and MitoQ-based antioxidant therapy alleviates this DNA-induced inflammation","volume":"560","author":"Ye W","year":"2023","unstructured":"Ye W, Wen C, Zeng A, Hu X. Increased levels of circulating oxidized mitochondrial DNA contribute to chronic inflammation in metabolic syndrome, and MitoQ-based antioxidant therapy alleviates this DNA-induced inflammation. Mol Cell Endocrinol. 2023, 560:111812. 10.1016\/j.mce.2022.111812","journal-title":"Mol Cell Endocrinol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2017.11.010","article-title":"BAY 60-2770 activates two isoforms of nitric oxide sensitive guanylyl cyclase: evidence for stable insertion of activator drugs","volume":"147","author":"S\u00f6mmer A","year":"2018","unstructured":"S\u00f6mmer A, Sandner P, Behrends S. BAY 60-2770 activates two isoforms of nitric oxide sensitive guanylyl cyclase: evidence for stable insertion of activator drugs. Biochem Pharmacol. 2018, 147:10-20. 10.1016\/j.bcp.2017.11.010","journal-title":"Biochem Pharmacol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1007\/5584_2017_112","article-title":"Combination of hydralazine and isosorbide-dinitrate in the treatment of patients with heart failure with reduced ejection fraction","volume":"1067","author":"Nyolczas N","year":"2018","unstructured":"Nyolczas N, D\u00e9k\u00e1ny M, Muk B, Szab\u00f3 B. Combination of hydralazine and isosorbide-dinitrate in the treatment of patients with heart failure with reduced ejection fraction. Adv Exp Med Biol. 2018, 1067:31-45. 10.1007\/5584_2017_112","journal-title":"Adv Exp Med Biol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1053\/j.semnuclmed.2020.02.007","article-title":"Ischemic heart disease: an update","volume":"50","author":"Jensen RV","year":"2020","unstructured":"Jensen RV, Hjortbak MV, B\u00f8tker HE. Ischemic heart disease: an update. Semin Nucl Med. 2020, 50:195-207. 10.1053\/j.semnuclmed.2020.02.007","journal-title":"Semin Nucl Med"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000207","article-title":"Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension","volume":"131","author":"Rosendorff C","year":"2015","unstructured":"Rosendorff C, Lackland DT, Allison M, et al.. Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension. Circulation. 2015, 131:e435-70. 10.1161\/CIR.0000000000000207","journal-title":"Circulation"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.1527","article-title":"Diagnosis and management of stable angina: a review","volume":"325","author":"Joshi PH","year":"2021","unstructured":"Joshi PH, de Lemos JA. Diagnosis and management of stable angina: a review. JAMA. 2021, 325:1765-78. 10.1001\/jama.2021.1527","journal-title":"JAMA"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2011.08.003","article-title":"Redox regulation of human protease-activated receptor-2 by activated factor X","volume":"51","author":"Jobi K","year":"2011","unstructured":"Jobi K, Rauch BH, Dangwal S, et al.. Redox regulation of human protease-activated receptor-2 by activated factor X. Free Radic Biol Med. 2011, 51:1758-64. 10.1016\/j.freeradbiomed.2011.08.003","journal-title":"Free Radic Biol Med"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S326716","article-title":"Platelet mediated inflammation in coronary artery disease with type 2 diabetes patients","volume":"14","author":"Johny E","year":"2021","unstructured":"Johny E, Bhaskar P, Alam MJ, Kuladhipati I, Das R, Adela R. Platelet mediated inflammation in coronary artery disease with type 2 diabetes patients. J Inflamm Res. 2021, 14:5131-47. 10.2147\/JIR.S326716","journal-title":"J Inflamm Res"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000003478","article-title":"Vasoprotective effects of NOX4 are mediated via polymerase and transient receptor potential melastatin 2 cation channels in endothelial cells","volume":"41","author":"Alves-Lopes R","year":"2023","unstructured":"Alves-Lopes R, Lacchini S, Neves KB, Harvey A, Montezano AC, Touyz RM. Vasoprotective effects of NOX4 are mediated via polymerase and transient receptor potential melastatin 2 cation channels in endothelial cells. J Hypertens. 2023, 41:1389-400. 10.1097\/HJH.0000000000003478","journal-title":"J Hypertens"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.115.307012","article-title":"Reactive oxygen species can provide atheroprotection via NOX4-dependent inhibition of inflammation and vascular remodeling","volume":"36","author":"Gray SP","year":"2016","unstructured":"Gray SP, Di Marco E, Kennedy K, et al.. Reactive oxygen species can provide atheroprotection via NOX4-dependent inhibition of inflammation and vascular remodeling. Arterioscler Thromb Vasc Biol. 2016, 36:295-307. 10.1161\/ATVBAHA.115.307012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv460","article-title":"The NADPH oxidase Nox4 has anti-atherosclerotic functions","volume":"36","author":"Sch\u00fcrmann C","year":"2015","unstructured":"Sch\u00fcrmann C, Rezende F, Kruse C, et al.. The NADPH oxidase Nox4 has anti-atherosclerotic functions. Eur Heart J. 2015, 36:3447-56. 10.1093\/eurheartj\/ehv460","journal-title":"Eur Heart J"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2023.0006","article-title":"Vascular redox signaling, endothelial nitric oxide synthase uncoupling, and endothelial dysfunction in the setting of transportation noise exposure or chronic treatment with organic nitrates","volume":"38","author":"M\u00fcnzel T","year":"2023","unstructured":"M\u00fcnzel T, Daiber A. Vascular redox signaling, endothelial nitric oxide synthase uncoupling, and endothelial dysfunction in the setting of transportation noise exposure or chronic treatment with organic nitrates. Antioxid Redox Signal. 2023, 38:1001-21. 10.1089\/ars.2023.0006","journal-title":"Antioxid Redox Signal"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.120.315187","article-title":"Oxidative stress product, 4-hydroxy-2-nonenal, induces the release of tissue factor-positive microvesicles from perivascular cells into circulation","volume":"41","author":"Ansari SA","year":"2021","unstructured":"Ansari SA, Keshava S, Pendurthi UR, Rao LV. Oxidative stress product, 4-hydroxy-2-nonenal, induces the release of tissue factor-positive microvesicles from perivascular cells into circulation. Arterioscler Thromb Vasc Biol. 2021, 41:250-65. 10.1161\/ATVBAHA.120.315187","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1007\/s00441-021-03471-2","article-title":"Endothelial cells and coagulation","volume":"387","author":"Neubauer K","year":"2022","unstructured":"Neubauer K, Zieger B. Endothelial cells and coagulation. Cell Tissue Res. 2022, 387:391-8. 10.1007\/s00441-021-03471-2","journal-title":"Cell Tissue Res"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0158355","article-title":"Factor XIa and thrombin generation are elevated in patients with acute coronary syndrome and predict recurrent cardiovascular events","volume":"11","author":"Loeffen R","year":"2016","unstructured":"Loeffen R, van Oerle R, Leers MP, Kragten JA, Crijns H, Spronk HM, Ten Cate H. Factor XIa and thrombin generation are elevated in patients with acute coronary syndrome and predict recurrent cardiovascular events. PLoS One. 2016, 11:e0158355. 10.1371\/journal.pone.0158355","journal-title":"PLoS One"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121656","article-title":"An injectable mitochondria-targeted nanodrug loaded-hydrogel for restoring mitochondrial function and hierarchically attenuating oxidative stress to reduce myocardial ischemia-reperfusion injury","volume":"287","author":"Zhang X","year":"2022","unstructured":"Zhang X, Sun Y, Yang R, Liu B, Liu Y, Yang J, Liu W. An injectable mitochondria-targeted nanodrug loaded-hydrogel for restoring mitochondrial function and hierarchically attenuating oxidative stress to reduce myocardial ischemia-reperfusion injury. Biomaterials. 2022, 287:121656. 10.1016\/j.biomaterials.2022.121656","journal-title":"Biomaterials"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-022-01151-0","article-title":"Pharmacological basis for abrogating myocardial reperfusion injury through a multi-target combined antioxidant therapy","volume":"61","author":"San-Mart\u00edn-Mart\u00ednez D","year":"2022","unstructured":"San-Mart\u00edn-Mart\u00ednez D, Serrano-Lemus D, Cornejo V, Gajardo AI, Rodrigo R. Pharmacological basis for abrogating myocardial reperfusion injury through a multi-target combined antioxidant therapy. Clin Pharmacokinet. 2022, 61:1203-18. 10.1007\/s40262-022-01151-0","journal-title":"Clin Pharmacokinet"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.3390\/nu12082199","article-title":"Vitamin C for cardiac protection during percutaneous coronary intervention: a systematic review of randomized controlled trials","volume":"12","author":"Khan SA","year":"2020","unstructured":"Khan SA, Bhattacharjee S, Ghani MO, Walden R, Chen QM. Vitamin C for cardiac protection during percutaneous coronary intervention: a systematic review of randomized controlled trials. Nutrients. 2020, 12:2199. 10.3390\/nu12082199","journal-title":"Nutrients"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13144127","article-title":"Anti-inflammatory and anti-oxidant properties of N-acetylcysteine: a fresh perspective","volume":"13","author":"Santus P","year":"2024","unstructured":"Santus P, Signorello JC, Danzo F, Lazzaroni G, Saad M, Radovanovic D. Anti-inflammatory and anti-oxidant properties of N-acetylcysteine: a fresh perspective. J Clin Med. 2024, 13:4127. 10.3390\/jcm13144127","journal-title":"J Clin Med"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2008.09.003","article-title":"The mitochondria-targeted antioxidant MitoQ protects against organ damage in a lipopolysaccharide-peptidoglycan model of sepsis","volume":"45","author":"Lowes DA","year":"2008","unstructured":"Lowes DA, Thottakam BM, Webster NR, Murphy MP, Galley HF. The mitochondria-targeted antioxidant MitoQ protects against organ damage in a lipopolysaccharide-peptidoglycan model of sepsis. Free Radic Biol Med. 2008, 45:1559-65. 10.1016\/j.freeradbiomed.2008.09.003","journal-title":"Free Radic Biol Med"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1007\/s12192-022-01273-1","article-title":"The mitochondria-targeted antioxidant MitoQ ameliorates myocardial ischemia-reperfusion injury by enhancing PINK1\/Parkin-mediated mitophagy in type 2 diabetic rats","volume":"27","author":"Ji Y","year":"2022","unstructured":"Ji Y, Leng Y, Lei S, et al.. The mitochondria-targeted antioxidant MitoQ ameliorates myocardial ischemia-reperfusion injury by enhancing PINK1\/Parkin-mediated mitophagy in type 2 diabetic rats. Cell Stress Chaperones. 2022, 27:353-67. 10.1007\/s12192-022-01273-1","journal-title":"Cell Stress Chaperones"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000147236.85306.15","article-title":"Cardiac arrest and cardiopulmonary resuscitation outcome reports: update and simplification of the Utstein templates for resuscitation registries: a statement for healthcare professionals from a task force of the International Liaison Committee on Resuscitation (American Heart Association, European Resuscitation Council, Australian Resuscitation Council, New Zealand Resuscitation Council, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Councils of Southern Africa)","volume":"110","author":"Jacobs I","year":"2004","unstructured":"Jacobs I, Nadkarni V, Bahr J, et al.. Cardiac arrest and cardiopulmonary resuscitation outcome reports: update and simplification of the Utstein templates for resuscitation registries: a statement for healthcare professionals from a task force of the International Liaison Committee on Resuscitation (American Heart Association, European Resuscitation Council, Australian Resuscitation Council, New Zealand Resuscitation Council, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Councils of Southern Africa). Circulation. 2004, 110:3385-97. 10.1161\/01.CIR.0000147236.85306.15","journal-title":"Circulation"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19020417","article-title":"Interplay between ROS and antioxidants during ischemia-reperfusion injuries in cardiac and skeletal muscle","volume":"19","author":"Zhou T","year":"2018","unstructured":"Zhou T, Prather ER, Garrison DE, Zuo L. Interplay between ROS and antioxidants during ischemia-reperfusion injuries in cardiac and skeletal muscle. Int J Mol Sci. 2018, 19:417. 10.3390\/ijms19020417","journal-title":"Int J Mol Sci"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11061213","article-title":"Resolution of inflammation after skeletal muscle ischemia-reperfusion injury: a focus on the lipid mediators lipoxins, resolvins, protectins and maresins","volume":"11","author":"Barnig C","year":"2022","unstructured":"Barnig C, Lutzweiler G, Giannini M, Lejay A, Charles AL, Meyer A, Geny B. Resolution of inflammation after skeletal muscle ischemia-reperfusion injury: a focus on the lipid mediators lipoxins, resolvins, protectins and maresins. Antioxidants (Basel). 2022, 11:1213. 10.3390\/antiox11061213","journal-title":"Antioxidants (Basel)"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00356.2015","article-title":"Chronology of mitochondrial and cellular events during skeletal muscle ischemia-reperfusion","volume":"310","author":"Paradis S","year":"2016","unstructured":"Paradis S, Charles AL, Meyer A, et al.. Chronology of mitochondrial and cellular events during skeletal muscle ischemia-reperfusion. Am J Physiol Cell Physiol. 2016, 310:C968-82. 10.1152\/ajpcell.00356.2015","journal-title":"Am J Physiol Cell Physiol"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2023.0823-4","article-title":"Crosstalk among reactive oxygen species, autophagy and metabolism in myocardial ischemia and reperfusion stages","volume":"15","author":"Peng Y","year":"2024","unstructured":"Peng Y, Tao Y, Liu L, Zhang J, Wei B. Crosstalk among reactive oxygen species, autophagy and metabolism in myocardial ischemia and reperfusion stages. Aging Dis. 2024, 15:1075-107. 10.14336\/AD.2023.0823-4","journal-title":"Aging Dis"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1007\/s00395-022-00930-x","article-title":"Blunting TRPML1 channels protects myocardial ischemia\/reperfusion injury by restoring impaired cardiomyocyte autophagy","volume":"117","author":"Xing Y","year":"2022","unstructured":"Xing Y, Sui Z, Liu Y, et al.. Blunting TRPML1 channels protects myocardial ischemia\/reperfusion injury by restoring impaired cardiomyocyte autophagy. Basic Res Cardiol. 2022, 117:20. 10.1007\/s00395-022-00930-x","journal-title":"Basic Res Cardiol"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.023787","article-title":"Vitamin C Improves the outcomes of cardiopulmonary resuscitation and alters shedding of syndecan-1 and p38\/MAPK phosphorylation in a rat model","volume":"11","author":"Xiao Y","year":"2022","unstructured":"Xiao Y, Su C, Zhang G, et al.. Vitamin C Improves the outcomes of cardiopulmonary resuscitation and alters shedding of syndecan-1 and p38\/MAPK phosphorylation in a rat model. J Am Heart Assoc. 2022, 11:e023787. 10.1161\/JAHA.121.023787","journal-title":"J Am Heart Assoc"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.83.3.1006","article-title":"Treatment with deferoxamine during ischemia improves functional and metabolic recovery and reduces reperfusion-induced oxygen radical generation in rabbit hearts","volume":"83","author":"Williams RE","year":"1991","unstructured":"Williams RE, Zweier JL, Flaherty JT. Treatment with deferoxamine during ischemia improves functional and metabolic recovery and reduces reperfusion-induced oxygen radical generation in rabbit hearts. Circulation. 1991, 83:1006-14. 10.1161\/01.cir.83.3.1006","journal-title":"Circulation"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.031219","article-title":"Deferasirox targeting ferroptosis synergistically ameliorates myocardial ischemia reperfusion injury in conjunction with cyclosporine A","volume":"13","author":"Ishimaru K","year":"2024","unstructured":"Ishimaru K, Ikeda M, Miyamoto HD, et al.. Deferasirox targeting ferroptosis synergistically ameliorates myocardial ischemia reperfusion injury in conjunction with cyclosporine A. J Am Heart Assoc. 2024, 13:e031219. 10.1161\/JAHA.123.031219","journal-title":"J Am Heart Assoc"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1080\/00207454.2023.2273768","article-title":"Protective effect of MitoTEMPO against cardiac dysfunction caused by ischemia-reperfusion: MCAO stroke model study","volume":"134","author":"Akkoca A","year":"2024","unstructured":"Akkoca A, B\u00fcy\u00fckak\u0131ll\u0131 B, Ball\u0131 E, G\u00fcltekin B, \u00d6zbay E, Oru\u00e7 Demirba\u011f H, T\u00fcrkseven \u00c7H. Protective effect of MitoTEMPO against cardiac dysfunction caused by ischemia-reperfusion: MCAO stroke model study. Int J Neurosci. 2024, 134:1582-93. 10.1080\/00207454.2023.2273768","journal-title":"Int J Neurosci"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1038\/s41536-023-00315-1","article-title":"Engineered inhaled nanocatalytic therapy for ischemic cerebrovascular disease by inducing autophagy of abnormal mitochondria","volume":"8","author":"Wang D","year":"2023","unstructured":"Wang D, Li B, Wang S, et al.. Engineered inhaled nanocatalytic therapy for ischemic cerebrovascular disease by inducing autophagy of abnormal mitochondria. NPJ Regen Med. 2023, 8:44. 10.1038\/s41536-023-00315-1","journal-title":"NPJ Regen Med"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.847246","article-title":"Oxidative stress following intracerebral hemorrhage: from molecular mechanisms to therapeutic targets","volume":"13","author":"Zhang Y","year":"2022","unstructured":"Zhang Y, Khan S, Liu Y, Wu G, Yong VW, Xue M. Oxidative stress following intracerebral hemorrhage: from molecular mechanisms to therapeutic targets. Front Immunol. 2022, 13:847246. 10.3389\/fimmu.2022.847246","journal-title":"Front Immunol"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24076389","article-title":"The role of potential oxidative biomarkers in the prognosis of acute ischemic stroke and the exploration of antioxidants as possible preventive and treatment options","volume":"24","author":"Kamal FZ","year":"2023","unstructured":"Kamal FZ, Lefter R, Jaber H, Balmus IM, Ciobica A, Iordache AC. The role of potential oxidative biomarkers in the prognosis of acute ischemic stroke and the exploration of antioxidants as possible preventive and treatment options. Int J Mol Sci. 2023, 24:6389. 10.3390\/ijms24076389","journal-title":"Int J Mol Sci"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1124419","article-title":"Oxidative stress in cerebrovascular disease and associated diseases","volume":"14","author":"Kumar V","year":"2023","unstructured":"Kumar V, Bishayee K, Park S, Lee U, Kim J. Oxidative stress in cerebrovascular disease and associated diseases. Front Endocrinol (Lausanne). 2023, 14:1124419. 10.3389\/fendo.2023.1124419","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2016.06.027","article-title":"Adaptive regulation of the brain's antioxidant defences by neurons and astrocytes","volume":"100","author":"Baxter PS","year":"2016","unstructured":"Baxter PS, Hardingham GE. Adaptive regulation of the brain's antioxidant defences by neurons and astrocytes. Free Radic Biol Med. 2016, 100:147-52. 10.1016\/j.freeradbiomed.2016.06.027","journal-title":"Free Radic Biol Med"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1515\/revneuro-2019-0099","article-title":"Insights into the neuropathology of cerebral ischemia and its mechanisms","volume":"31","author":"Ahad MA","year":"2020","unstructured":"Ahad MA, Kumaran KR, Ning T, et al.. Insights into the neuropathology of cerebral ischemia and its mechanisms. Rev Neurosci. 2020, 31:521-38. 10.1515\/revneuro-2019-0099","journal-title":"Rev Neurosci"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.2011.186","article-title":"The two pathophysiologies of focal brain ischemia: implications for translational stroke research","volume":"32","author":"Hossmann KA","year":"2012","unstructured":"Hossmann KA. The two pathophysiologies of focal brain ischemia: implications for translational stroke research. J Cereb Blood Flow Metab. 2012, 32:1310-6. 10.1038\/jcbfm.2011.186","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-020-00856-z","article-title":"Resuscitating the globally ischemic brain: TTM and beyond","volume":"17","author":"Hosseini M","year":"2020","unstructured":"Hosseini M, Wilson RH, Crouzet C, Amirhekmat A, Wei KS, Akbari Y. Resuscitating the globally ischemic brain: TTM and beyond. Neurotherapeutics. 2020, 17:539-62. 10.1007\/s13311-020-00856-z","journal-title":"Neurotherapeutics"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11101966","article-title":"Role of NADPH oxidases in blood-brain barrier disruption and ischemic stroke","volume":"11","author":"Hernandes MS","year":"2022","unstructured":"Hernandes MS, Xu Q, Griendling KK. Role of NADPH oxidases in blood-brain barrier disruption and ischemic stroke. Antioxidants (Basel). 2022, 11:1966. 10.3390\/antiox11101966","journal-title":"Antioxidants (Basel)"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1002\/advs.201800781","article-title":"A broad-spectrum Ros-eliminating material for prevention of inflammation and drug-induced organ toxicity","volume":"5","author":"Li L","year":"2018","unstructured":"Li L, Guo J, Wang Y, et al.. A broad-spectrum Ros-eliminating material for prevention of inflammation and drug-induced organ toxicity. Adv Sci (Weinh). 2018, 5:1800781. 10.1002\/advs.201800781","journal-title":"Adv Sci (Weinh)"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.120.032266","article-title":"Reactive oxygen species scavenger in acute intracerebral hemorrhage patients: a multicenter, randomized controlled trial","volume":"52","author":"Kim M","year":"2021","unstructured":"Kim M, Byun J, Chung Y, et al.. Reactive oxygen species scavenger in acute intracerebral hemorrhage patients: a multicenter, randomized controlled trial. Stroke. 2021, 52:1172-81. 10.1161\/STROKEAHA.120.032266","journal-title":"Stroke"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2021.10.020","article-title":"Nanomedicines, an emerging therapeutic regimen for treatment of ischemic cerebral stroke: a review","volume":"340","author":"Chen W","year":"2021","unstructured":"Chen W, Jiang L, Hu Y, et al.. Nanomedicines, an emerging therapeutic regimen for treatment of ischemic cerebral stroke: a review. J Control Release. 2021, 340:342-60. 10.1016\/j.jconrel.2021.10.020","journal-title":"J Control Release"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.1c04753","article-title":"Targeted treatment of ischemic stroke by bioactive nanoparticle-derived reactive oxygen species responsive and inflammation-resolving nanotherapies","volume":"15","author":"Yuan J","year":"2021","unstructured":"Yuan J, Li L, Yang Q, et al.. Targeted treatment of ischemic stroke by bioactive nanoparticle-derived reactive oxygen species responsive and inflammation-resolving nanotherapies. ACS Nano. 2021, 15:16076-94. 10.1021\/acsnano.1c04753","journal-title":"ACS Nano"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0300958","article-title":"miR-214 aggravates oxidative stress in thalassemic erythroid cells by targeting ATF4","volume":"19","author":"Penglong T","year":"2024","unstructured":"Penglong T, Saensuwanna A, Jantapaso H, et al.. miR-214 aggravates oxidative stress in thalassemic erythroid cells by targeting ATF4. PLoS One. 2024, 19:e0300958. 10.1371\/journal.pone.0300958","journal-title":"PLoS One"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1111\/febs.14606","article-title":"Oxidative stress, eryptosis and anemia: a pivotal mechanistic nexus in systemic diseases","volume":"286","author":"Bissinger R","year":"2019","unstructured":"Bissinger R, Bhuyan AA, Qadri SM, Lang F. Oxidative stress, eryptosis and anemia: a pivotal mechanistic nexus in systemic diseases. FEBS J. 2019, 286:826-54. 10.1111\/febs.14606","journal-title":"FEBS J"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6639199","article-title":"Reactive oxygen species and their involvement in red blood cell damage in chronic kidney disease","volume":"2021","author":"Gwozdzinski K","year":"2021","unstructured":"Gwozdzinski K, Pieniazek A, Gwozdzinski L. Reactive oxygen species and their involvement in red blood cell damage in chronic kidney disease. Oxid Med Cell Longev. 2021, 2021:6639199. 10.1155\/2021\/6639199","journal-title":"Oxid Med Cell Longev"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2014.00084","article-title":"Red blood cell oxidative stress impairs oxygen delivery and induces red blood cell aging","volume":"5","author":"Mohanty JG","year":"2014","unstructured":"Mohanty JG, Nagababu E, Rifkind JM. Red blood cell oxidative stress impairs oxygen delivery and induces red blood cell aging. Front Physiol. 2014, 5:84. 10.3389\/fphys.2014.00084","journal-title":"Front Physiol"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/537954","article-title":"Treatment of \u03b2-thalassemia\/hemoglobin E with antioxidant cocktails results in decreased oxidative stress, increased hemoglobin concentration, and improvement of the hypercoagulable state","volume":"2015","author":"Yanpanitch OU","year":"2015","unstructured":"Yanpanitch OU, Hatairaktham S, Charoensakdi R, et al.. Treatment of \u03b2-thalassemia\/hemoglobin E with antioxidant cocktails results in decreased oxidative stress, increased hemoglobin concentration, and improvement of the hypercoagulable state. Oxid Med Cell Longev. 2015, 2015:537954. 10.1155\/2015\/537954","journal-title":"Oxid Med Cell Longev"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2018.00689","article-title":"Increased reactive oxygen species and cell cycle defects contribute to anemia in the RASA3 mutant mouse model scat","volume":"9","author":"Hartman ES","year":"2018","unstructured":"Hartman ES, Brindley EC, Papoin J, Ciciotte SL, Zhao Y, Peters LL, Blanc L. Increased reactive oxygen species and cell cycle defects contribute to anemia in the RASA3 mutant mouse model scat. Front Physiol. 2018, 9:689. 10.3389\/fphys.2018.00689","journal-title":"Front Physiol"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1007\/s12288-020-01340-6","article-title":"Low dose iron therapy in children with iron deficiency: DNA damage and oxidant stress markers","volume":"37","author":"Hamed HM","year":"2021","unstructured":"Hamed HM, Motawie AA, Abd Al-Aziz AM, et al.. Low dose iron therapy in children with iron deficiency: DNA damage and oxidant stress markers. Indian J Hematol Blood Transfus. 2021, 37:287-94. 10.1007\/s12288-020-01340-6","journal-title":"Indian J Hematol Blood Transfus"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtemb.2025.127591","article-title":"Deciphering the role of hepcidin in iron metabolism and anemia management","volume":"87","author":"Kesharwani P","year":"2025","unstructured":"Kesharwani P, Dash D, Koiri RK. Deciphering the role of hepcidin in iron metabolism and anemia management. J Trace Elem Med Biol. 2025, 87:127591. 10.1016\/j.jtemb.2025.127591","journal-title":"J Trace Elem Med Biol"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/4357756","article-title":"Changes in hepcidin levels in an animal model of anemia of chronic inflammation: mechanistic insights related to iron supplementation and hepcidin regulation","volume":"2021","author":"Kim HB","year":"2021","unstructured":"Kim HB, Jun JH, Shim JK, Oh JE, Lee C, Kwak YL. Changes in hepcidin levels in an animal model of anemia of chronic inflammation: mechanistic insights related to iron supplementation and hepcidin regulation. Oxid Med Cell Longev. 2021, 2021:4357756. 10.1155\/2021\/4357756","journal-title":"Oxid Med Cell Longev"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1002\/stem.1261","article-title":"Cell autonomous and nonautonomous mechanisms drive hematopoietic stem\/progenitor cell loss in the absence of DNA repair","volume":"31","author":"Cho JS","year":"2013","unstructured":"Cho JS, Kook SH, Robinson AR, Niedernhofer LJ, Lee BC. Cell autonomous and nonautonomous mechanisms drive hematopoietic stem\/progenitor cell loss in the absence of DNA repair. Stem Cells. 2013, 31:511-25. 10.1002\/stem.1261","journal-title":"Stem Cells"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.3390\/vetsci9050229","article-title":"Impact of acute blood loss on clinical, hematological, biochemical, and oxidative stress variables in sheep","volume":"9","author":"Sousa RS","year":"2022","unstructured":"Sousa RS, Sousa CS, Oliveira FL, et al.. Impact of acute blood loss on clinical, hematological, biochemical, and oxidative stress variables in sheep. Vet Sci. 2022, 9:229. 10.3390\/vetsci9050229","journal-title":"Vet Sci"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26992","article-title":"Increased blood reactive oxygen species and hepcidin in obstructive sleep apnea precludes expected erythrocytosis","volume":"98","author":"Song J","year":"2023","unstructured":"Song J, Sundar KM, Horvathova M, et al.. Increased blood reactive oxygen species and hepcidin in obstructive sleep apnea precludes expected erythrocytosis. Am J Hematol. 2023, 98:1265-76. 10.1002\/ajh.26992","journal-title":"Am J Hematol"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-07-441188","article-title":"Erythrocyte NADPH oxidase activity modulated by Rac GTPases, PKC, and plasma cytokines contributes to oxidative stress in sickle cell disease","volume":"121","author":"George A","year":"2013","unstructured":"George A, Pushkaran S, Konstantinidis DG, et al.. Erythrocyte NADPH oxidase activity modulated by Rac GTPases, PKC, and plasma cytokines contributes to oxidative stress in sickle cell disease. Blood. 2013, 121:2099-107. 10.1182\/blood-2012-07-441188","journal-title":"Blood"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.3390\/medsci7020017","article-title":"Oxidative profile of patients with sickle cell disease","volume":"7","author":"Antwi-Boasiako C","year":"2019","unstructured":"Antwi-Boasiako C, Dankwah GB, Aryee R, Hayfron-Benjamin C, Donkor ES, Campbell AD. Oxidative profile of patients with sickle cell disease. Med Sci (Basel). 2019, 7:17. 10.3390\/medsci7020017","journal-title":"Med Sci (Basel)"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10020296","article-title":"Sickle cell disease: Role of oxidative stress and antioxidant therapy","volume":"10","author":"Vona R","year":"2021","unstructured":"Vona R, Sposi NM, Mattia L, Gambardella L, Straface E, Pietraforte D. Sickle cell disease: Role of oxidative stress and antioxidant therapy. Antioxidants (Basel). 2021, 10:296. 10.3390\/antiox10020296","journal-title":"Antioxidants (Basel)"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00454","article-title":"The red blood cell-inflammation vicious circle in sickle cell disease","volume":"11","author":"Nader E","year":"2020","unstructured":"Nader E, Romana M, Connes P. The red blood cell-inflammation vicious circle in sickle cell disease. Front Immunol. 2020, 11:454. 10.3389\/fimmu.2020.00454","journal-title":"Front Immunol"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathmechdis-012418-012838","article-title":"Pathophysiology of sickle cell disease","volume":"14","author":"Sundd P","year":"2019","unstructured":"Sundd P, Gladwin MT, Novelli EM. Pathophysiology of sickle cell disease. Annu Rev Pathol. 2019, 14:263-92. 10.1146\/annurev-pathmechdis-012418-012838","journal-title":"Annu Rev Pathol"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10101608","article-title":"The role of RBC oxidative stress in sickle cell disease: from the molecular basis to pathologic implications","volume":"10","author":"Wang Q","year":"2021","unstructured":"Wang Q, Zennadi R. The role of RBC oxidative stress in sickle cell disease: from the molecular basis to pathologic implications. Antioxidants (Basel). 2021, 10:1608. 10.3390\/antiox10101608","journal-title":"Antioxidants (Basel)"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-011-1404-z","article-title":"N-acetylcysteine reduces oxidative stress in sickle cell patients","volume":"91","author":"Nur E","year":"2012","unstructured":"Nur E, Brandjes DP, Teerlink T, et al.. N-acetylcysteine reduces oxidative stress in sickle cell patients. Ann Hematol. 2012, 91:1097-105. 10.1007\/s00277-011-1404-z","journal-title":"Ann Hematol"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2010.05577.x","article-title":"The role of antioxidants and iron chelators in the treatment of oxidative stress in thalassemia","volume":"1202","author":"Fibach E","year":"2010","unstructured":"Fibach E, Rachmilewitz EA. The role of antioxidants and iron chelators in the treatment of oxidative stress in thalassemia. Ann NY Acad Sci. 2010, 1202:10-6. 10.1111\/j.1749-6632.2010.05577.x","journal-title":"Ann NY Acad Sci"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001220","article-title":"Cardiovascular management of patients undergoing hematopoietic stem cell transplantation: from Pretransplantation to survivorship: a scientific statement from the American Heart Association","volume":"149","author":"Hayek SS","year":"2024","unstructured":"Hayek SS, Zaha VG, Bogle C, et al.. Cardiovascular management of patients undergoing hematopoietic stem cell transplantation: from Pretransplantation to survivorship: a scientific statement from the American Heart Association. Circulation. 2024, 149:e1113-27. 10.1161\/CIR.0000000000001220","journal-title":"Circulation"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.00435","article-title":"Recent advances in the treatment of sickle cell disease","volume":"11","author":"Salinas Cisneros G","year":"2020","unstructured":"Salinas Cisneros G, Thein SL. Recent advances in the treatment of sickle cell disease. Front Physiol. 2020, 11:435. 10.3389\/fphys.2020.00435","journal-title":"Front Physiol"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.889875","article-title":"Reactive oxygen species and metabolism in leukemia: a dangerous liaison","volume":"13","author":"Romo-Gonz\u00e1lez M","year":"2022","unstructured":"Romo-Gonz\u00e1lez M, Ijurko C, Hern\u00e1ndez-Hern\u00e1ndez \u00c1. Reactive oxygen species and metabolism in leukemia: a dangerous liaison. Front Immunol. 2022, 13:889875. 10.3389\/fimmu.2022.889875","journal-title":"Front Immunol"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-024-03696-4","article-title":"Several lines of antioxidant defense against oxidative stress: antioxidant enzymes, nanomaterials with multiple enzyme-mimicking activities, and low-molecular-weight antioxidants","volume":"98","author":"Jomova K","year":"2024","unstructured":"Jomova K, Alomar SY, Alwasel SH, Nepovimova E, Kuca K, Valko M. Several lines of antioxidant defense against oxidative stress: antioxidant enzymes, nanomaterials with multiple enzyme-mimicking activities, and low-molecular-weight antioxidants. Arch Toxicol. 2024, 98:1323-67. 10.1007\/s00204-024-03696-4","journal-title":"Arch Toxicol"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20236003","article-title":"The role of reactive oxygen species in acute myeloid leukaemia","volume":"20","author":"Sillar JR","year":"2019","unstructured":"Sillar JR, Germon ZP, DeIuliis GN, Dun MD. The role of reactive oxygen species in acute myeloid leukaemia. Int J Mol Sci. 2019, 20:6003. 10.3390\/ijms20236003","journal-title":"Int J Mol Sci"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1042\/bj3480093","article-title":"JNK (c-Jun N-terminal kinase) and p38 activation in receptor-mediated and chemically-induced apoptosis of T-cells: differential requirements for caspase activation","volume":"348","author":"MacFarlane M","year":"2000","unstructured":"MacFarlane M, Cohen GM, Dickens M. JNK (c-Jun N-terminal kinase) and p38 activation in receptor-mediated and chemically-induced apoptosis of T-cells: differential requirements for caspase activation. Biochem J. 2000, 348:93-101. 10.1042\/bj3480093","journal-title":"Biochem J"},{"key":"ref101","doi-asserted-by":"crossref","DOI":"10.1177\/1947601913485413","article-title":"C-Jun N-terminal kinases mediate a wide range of targets in the metastatic cascade","volume":"4","author":"Ebelt ND","year":"2013","unstructured":"Ebelt ND, Cantrell MA, Van Den Berg CL. C-Jun N-terminal kinases mediate a wide range of targets in the metastatic cascade. Genes Cancer. 2013, 4:378-87.","journal-title":"Genes Cancer"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2021.1970217","article-title":"P38 MAPK\/AKT signalling is involved in IL-33-mediated anti-apoptosis in childhood acute lymphoblastic leukaemia blast cells","volume":"53","author":"Wang Y","year":"2021","unstructured":"Wang Y, Hou H, Liang Z, et al.. P38 MAPK\/AKT signalling is involved in IL-33-mediated anti-apoptosis in childhood acute lymphoblastic leukaemia blast cells. Ann Med. 2021, 53:1461-9. 10.1080\/07853890.2021.1970217","journal-title":"Ann Med"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.1016\/bs.acr.2024.04.008","article-title":"Redox, cysteines, and kinases-A triad sustaining myeloid leukemia","volume":"164","author":"Marensi V","year":"2024","unstructured":"Marensi V. Redox, cysteines, and kinases-A triad sustaining myeloid leukemia. Adv Cancer Res. 2024, 164:1-68. 10.1016\/bs.acr.2024.04.008","journal-title":"Adv Cancer Res"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.3390\/ijms221910442","article-title":"B cell lymphoma 2: a potential therapeutic target for cancer therapy","volume":"22","author":"Alam M","year":"2021","unstructured":"Alam M, Ali S, Mohammad T, Hasan GM, Yadav DK, Hassan MI. B cell lymphoma 2: a potential therapeutic target for cancer therapy. Int J Mol Sci. 2021, 22:10442. 10.3390\/ijms221910442","journal-title":"Int J Mol Sci"},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27092665","article-title":"Potential therapeutic targets of resveratrol, a plant polyphenol, and its role in the therapy of various types of cancer","volume":"27","author":"Almatroodi SA","year":"2022","unstructured":"Almatroodi SA, A Alsahli M, S M Aljohani A, Alhumaydhi FA, Babiker AY, Khan AA, Rahmani AH. Potential therapeutic targets of resveratrol, a plant polyphenol, and its role in the therapy of various types of cancer. Molecules. 2022, 27:2665. 10.3390\/molecules27092665","journal-title":"Molecules"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.5114\/aoms.2019.89918","article-title":"The role of NF-\u03baB and Smac\/DIABLO proteins in the treatment response and survival of acute myeloid leukemia patients","volume":"17","author":"Pluta A","year":"2021","unstructured":"Pluta A, Robak T, Cebula B, et al.. The role of NF-\u03baB and Smac\/DIABLO proteins in the treatment response and survival of acute myeloid leukemia patients. Arch Med Sci. 2021, 17:700-7. 10.5114\/aoms.2019.89918","journal-title":"Arch Med Sci"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2015.08.021","article-title":"Ellagic acid, a polyphenolic compound, selectively induces ROS-mediated apoptosis in cancerous B-lymphocytes of CLL patients by directly targeting mitochondria","volume":"6","author":"Salimi A","year":"2015","unstructured":"Salimi A, Roudkenar MH, Sadeghi L, Mohseni A, Seydi E, Pirahmadi N, Pourahmad J. Ellagic acid, a polyphenolic compound, selectively induces ROS-mediated apoptosis in cancerous B-lymphocytes of CLL patients by directly targeting mitochondria. Redox Biol. 2015, 6:461-71. 10.1016\/j.redox.2015.08.021","journal-title":"Redox Biol"},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.1080\/01635581.2016.1235717","article-title":"Selective anticancer activity of acacetin against chronic lymphocytic leukemia using both in vivo and in vitro methods: key role of oxidative stress and cancerous mitochondria","volume":"68","author":"Salimi A","year":"2016","unstructured":"Salimi A, Roudkenar MH, Sadeghi L, Mohseni A, Seydi E, Pirahmadi N, Pourahmad J. Selective anticancer activity of acacetin against chronic lymphocytic leukemia using both in vivo and in vitro methods: key role of oxidative stress and cancerous mitochondria. Nutr Cancer. 2016, 68:1404-16. 10.1080\/01635581.2016.1235717","journal-title":"Nutr Cancer"},{"key":"ref109","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.7-suppl_1-14","article-title":"Molecular targets of arsenic trioxide in malignant cells","volume":"7","author":"Miller WH Jr","year":"2002","unstructured":"Miller WH Jr. Molecular targets of arsenic trioxide in malignant cells. Oncologist. 2002, 7:14-9. 10.1634\/theoncologist.7-suppl_1-14","journal-title":"Oncologist"},{"key":"ref110","doi-asserted-by":"publisher","DOI":"10.1007\/s11356-016-8215-7","article-title":"Arsenic trioxide induces ROS activity and DNA damage, leading to G0\/G1 extension in skin fibroblasts through the ATM-ATR-associated Chk pathway","volume":"24","author":"Chayapong J","year":"2017","unstructured":"Chayapong J, Madhyastha H, Madhyastha R, et al.. Arsenic trioxide induces ROS activity and DNA damage, leading to G0\/G1 extension in skin fibroblasts through the ATM-ATR-associated Chk pathway. Environ Sci Pollut Res Int. 2017, 24:5316-25. 10.1007\/s11356-016-8215-7","journal-title":"Environ Sci Pollut Res Int"},{"key":"ref111","doi-asserted-by":"publisher","DOI":"10.1177\/15347354211065038","article-title":"Is 6-shogaol an effective phytochemical for patients with lower-risk myelodysplastic syndrome? A narrative review","volume":"20","author":"Ooi SL","year":"2021","unstructured":"Ooi SL, Campbell R, Pak SC, et al.. Is 6-shogaol an effective phytochemical for patients with lower-risk myelodysplastic syndrome? A narrative review. Integr Cancer Ther. 2021, 20:15347354211065038. 10.1177\/15347354211065038","journal-title":"Integr Cancer Ther"},{"key":"ref112","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00278-x","article-title":"Haemophilia","volume":"7","author":"Berntorp E","year":"2021","unstructured":"Berntorp E, Fischer K, Hart DP, Mancuso ME, Stephensen D, Shapiro AD, Blanchette V. Haemophilia. Nat Rev Dis Primers. 2021, 7:45. 10.1038\/s41572-021-00278-x","journal-title":"Nat Rev Dis Primers"},{"key":"ref113","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11061113","article-title":"Pain in hemophilia: Unexplored role of oxidative stress","volume":"11","author":"Fouda R","year":"2022","unstructured":"Fouda R, Argueta DA, Gupta K. Pain in hemophilia: Unexplored role of oxidative stress. Antioxidants (Basel). 2022, 11:1113. 10.3390\/antiox11061113","journal-title":"Antioxidants (Basel)"},{"key":"ref114","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14075","article-title":"Inhibition of Fenton reaction is a novel mechanism to explain the therapeutic effect of intra-articular injection of PRP in patients with chronic haemophilic synovitis","volume":"26","author":"Caviglia H","year":"2020","unstructured":"Caviglia H, Daffunchio C, Galatro G, et al.. Inhibition of Fenton reaction is a novel mechanism to explain the therapeutic effect of intra-articular injection of PRP in patients with chronic haemophilic synovitis. Haemophilia. 2020, 26:e187-93. 10.1111\/hae.14075","journal-title":"Haemophilia"},{"key":"ref115","doi-asserted-by":"publisher","DOI":"10.3390\/cells10102549","article-title":"New insights into the pivotal role of iron\/heme metabolism in TLR4\/NF-\u03bab signaling-mediated inflammatory responses in human monocytes","volume":"10","author":"Kang DY","year":"2021","unstructured":"Kang DY, Sp N, Jo ES, Lee JM, Jang KJ. New insights into the pivotal role of iron\/heme metabolism in TLR4\/NF-\u03bab signaling-mediated inflammatory responses in human monocytes. Cells. 2021, 10:2549. 10.3390\/cells10102549","journal-title":"Cells"},{"key":"ref116","article-title":"In vitro study of a liposomal curcumin formulation (Lipocurc): toxicity and biological activity in synovial fibroblasts and macrophages. In","volume":"30","author":"Kloesch B","year":"2016","unstructured":"Kloesch B, Gober L, Loebsch S, Vcelar B, Helson L, Steiner G. In vitro study of a liposomal curcumin formulation (Lipocurc): toxicity and biological activity in synovial fibroblasts and macrophages. In. Vivo. 2016, 30:413-9.","journal-title":"Vivo"},{"key":"ref117","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2020.1685867","article-title":"Curcumin: hopeful treatment of hemophilic arthropathy via inhibition of inflammation and angiogenesis","volume":"13","author":"Norooznezhad F","year":"2020","unstructured":"Norooznezhad F, Rodriguez-Merchan EC, Asadi S, Norooznezhad AH. Curcumin: hopeful treatment of hemophilic arthropathy via inhibition of inflammation and angiogenesis. Expert Rev Hematol. 2020, 13:5-11. 10.1080\/17474086.2020.1685867","journal-title":"Expert Rev Hematol"},{"key":"ref118","article-title":"Thrombocytopenia: Evaluation and management","volume":"106","author":"Gauer RL","year":"2022","unstructured":"Gauer RL, Whitaker DJ. Thrombocytopenia: Evaluation and management. Am Fam Physician. 2022, 106:288-98.","journal-title":"Am Fam Physician"},{"key":"ref119","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2023.04.001","article-title":"Increased reactive oxygen species lead to overactivation of platelets in essential thrombocythemia","volume":"226","author":"Dong H","year":"2023","unstructured":"Dong H, Li H, Fang L, et al.. Increased reactive oxygen species lead to overactivation of platelets in essential thrombocythemia. Thromb Res. 2023, 226:18-29. 10.1016\/j.thromres.2023.04.001","journal-title":"Thromb Res"},{"key":"ref120","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.106777","article-title":"Research progress on the interaction between oxidative stress and platelets: another avenue for cancer?","volume":"191","author":"Zhang X","year":"2023","unstructured":"Zhang X, Yu S, Li X, et al.. Research progress on the interaction between oxidative stress and platelets: another avenue for cancer?. Pharmacol Res. 2023, 191:106777. 10.1016\/j.phrs.2023.106777","journal-title":"Pharmacol Res"},{"key":"ref121","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2017.07.073","article-title":"Cell-free methemoglobin drives platelets to apoptosis via mitochondrial ROS-mediated activation of JNK and p38 MAP kinase","volume":"491","author":"NaveenKumar SK","year":"2017","unstructured":"NaveenKumar SK, Hemshekhar M, Sundaram MS, Kemparaju K, Girish KS. Cell-free methemoglobin drives platelets to apoptosis via mitochondrial ROS-mediated activation of JNK and p38 MAP kinase. Biochem Biophys Res Commun. 2017, 491:183-91. 10.1016\/j.bbrc.2017.07.073","journal-title":"Biochem Biophys Res Commun"},{"key":"ref122","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2013.03.001","article-title":"Immune thrombocytopenia","volume":"27","author":"Kistangari G","year":"2013","unstructured":"Kistangari G, McCrae KR. Immune thrombocytopenia. Hematol Oncol Clin North Am. 2013, 27:495-520. 10.1016\/j.hoc.2013.03.001","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref123","doi-asserted-by":"publisher","DOI":"10.1111\/sji.12048","article-title":"Antioxidant status and oxidative stress in patients with chronic ITP","volume":"77","author":"Jin CQ","year":"2013","unstructured":"Jin CQ, Dong HX, Cheng PP, Zhou JW, Zheng BY, Liu F. Antioxidant status and oxidative stress in patients with chronic ITP. Scand J Immunol. 2013, 77:482-7. 10.1111\/sji.12048","journal-title":"Scand J Immunol"},{"key":"ref124","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24054438","article-title":"Novel biomarkers for diagnosis and monitoring of immune thrombocytopenia","volume":"24","author":"Allegra A","year":"2023","unstructured":"Allegra A, Cicero N, Mirabile G, Giorgianni CM, Gangemi S. Novel biomarkers for diagnosis and monitoring of immune thrombocytopenia. Int J Mol Sci. 2023, 24:4438. 10.3390\/ijms24054438","journal-title":"Int J Mol Sci"},{"key":"ref125","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1722621","article-title":"Protocatechuic acid protects platelets from apoptosis via inhibiting oxidative stress-mediated PI3K\/Akt\/GSK3\u03b2 signaling","volume":"121","author":"Ya F","year":"2021","unstructured":"Ya F, Li K, Chen H, et al.. Protocatechuic acid protects platelets from apoptosis via inhibiting oxidative stress-mediated PI3K\/Akt\/GSK3\u03b2 signaling. Thromb Haemost. 2021, 121:931-43. 10.1055\/s-0040-1722621","journal-title":"Thromb Haemost"},{"key":"ref126","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27144400","article-title":"A comprehensive review on the benefits and problems of curcumin with respect to human health","volume":"27","author":"Liu S","year":"2022","unstructured":"Liu S, Liu J, He L, et al.. A comprehensive review on the benefits and problems of curcumin with respect to human health. Molecules. 2022, 27:4400. 10.3390\/molecules27144400","journal-title":"Molecules"},{"key":"ref127","doi-asserted-by":"publisher","DOI":"10.1134\/S0006297924030039","article-title":"Oxidative stress-induced platelet apoptosis\/activation: alleviation by purified curcumin via ASK1-JNK\/p-38 pathway","volume":"89","author":"Manikanta K","year":"2024","unstructured":"Manikanta K, Paul M, Sandesha VD, et al.. Oxidative stress-induced platelet apoptosis\/activation: alleviation by purified curcumin via ASK1-JNK\/p-38 pathway. Biochemistry (Mosc). 2024, 89:417-30. 10.1134\/S0006297924030039","journal-title":"Biochemistry (Mosc)"},{"key":"ref128","doi-asserted-by":"publisher","DOI":"10.3390\/nu14081633","article-title":"Resveratrol inhibits metabolism and affects blood platelet function in type 2 diabetes","volume":"14","author":"Michno A","year":"2022","unstructured":"Michno A, Gru\u017cewska K, Ronowska A, Gul-Hinc S, Zy\u015bk M, Jankowska-Kulawy A. Resveratrol inhibits metabolism and affects blood platelet function in type 2 diabetes. Nutrients. 2022, 14:1633. 10.3390\/nu14081633","journal-title":"Nutrients"},{"key":"ref129","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.14578","article-title":"Diagnosis and treatment of myelodysplastic syndromes: a review","volume":"328","author":"Sekeres MA","year":"2022","unstructured":"Sekeres MA, Taylor J. Diagnosis and treatment of myelodysplastic syndromes: a review. JAMA. 2022, 328:872-80. 10.1001\/jama.2022.14578","journal-title":"JAMA"},{"key":"ref130","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2021.08.018","article-title":"Redox metabolism: ROS as specific molecular regulators of cell signaling and function","volume":"81","author":"Lennicke C","year":"2021","unstructured":"Lennicke C, Cochem\u00e9 HM. Redox metabolism: ROS as specific molecular regulators of cell signaling and function. Mol Cell. 2021, 81:3691-707. 10.1016\/j.molcel.2021.08.018","journal-title":"Mol Cell"},{"key":"ref131","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-020-0230-3","article-title":"Reactive oxygen species (ROS) as pleiotropic physiological signalling agents","volume":"21","author":"Sies H","year":"2020","unstructured":"Sies H, Jones DP. Reactive oxygen species (ROS) as pleiotropic physiological signalling agents. Nat Rev Mol Cell Biol. 2020, 21:363-83. 10.1038\/s41580-020-0230-3","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref132","doi-asserted-by":"publisher","DOI":"10.1177\/147323001103900539","article-title":"Oxidative stress levels in myelodysplastic syndrome patients: their relationship to serum ferritin and haemoglobin values","volume":"39","author":"Saigo K","year":"2011","unstructured":"Saigo K, Takenokuchi M, Hiramatsu Y, et al.. Oxidative stress levels in myelodysplastic syndrome patients: their relationship to serum ferritin and haemoglobin values. J Int Med Res. 2011, 39:1941-5. 10.1177\/147323001103900539","journal-title":"J Int Med Res"},{"key":"ref133","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2014.5941","article-title":"Reactive oxygen species regulate hematopoietic stem cell self-renewal, migration and development, as well as their bone marrow microenvironment","volume":"21","author":"Ludin A","year":"2014","unstructured":"Ludin A, Gur-Cohen S, Golan K, et al.. Reactive oxygen species regulate hematopoietic stem cell self-renewal, migration and development, as well as their bone marrow microenvironment. Antioxid Redox Signal. 2014, 21:1605-19. 10.1089\/ars.2014.5941","journal-title":"Antioxid Redox Signal"},{"key":"ref134","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000677","article-title":"Bone marrow oxidative stress and specific antioxidant signatures in myelodysplastic syndromes","volume":"3","author":"Picou F","year":"2019","unstructured":"Picou F, Vignon C, Debeissat C, et al.. Bone marrow oxidative stress and specific antioxidant signatures in myelodysplastic syndromes. Blood Adv. 2019, 3:4271-9. 10.1182\/bloodadvances.2019000677","journal-title":"Blood Adv"},{"key":"ref135","doi-asserted-by":"publisher","DOI":"10.1186\/s11658-024-00570-0","article-title":"Role of reactive oxygen species in myelodysplastic syndromes","volume":"29","author":"Jing Q","year":"2024","unstructured":"Jing Q, Zhou C, Zhang J, et al.. Role of reactive oxygen species in myelodysplastic syndromes. Cell Mol Biol Lett. 2024, 29:53. 10.1186\/s11658-024-00570-0","journal-title":"Cell Mol Biol Lett"},{"key":"ref136","doi-asserted-by":"publisher","DOI":"10.1179\/102453308X343428","article-title":"Results of combination therapy with amifostine, pentoxifylline, ciprofloxacin and dexamethasone in patients with myelodysplastic syndrome and acute myeloid leukemia","volume":"13","author":"Erikci AA","year":"2008","unstructured":"Erikci AA, Ozturk A, Karagoz B, Bilgi O, Turken O, Top C, Kandemir EG. Results of combination therapy with amifostine, pentoxifylline, ciprofloxacin and dexamethasone in patients with myelodysplastic syndrome and acute myeloid leukemia. Hematology. 2008, 13:289-92. 10.1179\/102453308X343428","journal-title":"Hematology"},{"key":"ref137","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25010112","article-title":"The history of nanoscience and nanotechnology: from chemical-physical applications to nanomedicine","volume":"25","author":"Bayda S","year":"2019","unstructured":"Bayda S, Adeel M, Tuccinardi T, Cordani M, Rizzolio F. The history of nanoscience and nanotechnology: from chemical-physical applications to nanomedicine. Molecules. 2019, 25:112. 10.3390\/molecules25010112","journal-title":"Molecules"},{"key":"ref138","doi-asserted-by":"publisher","DOI":"10.2217\/nnm.16.3","article-title":"Nanotechnology in diagnosis and treatment of coronary artery disease","volume":"11","author":"Karimi M","year":"2016","unstructured":"Karimi M, Zare H, Bakhshian Nik A, et al.. Nanotechnology in diagnosis and treatment of coronary artery disease. Nanomedicine (Lond). 2016, 11:513-30. 10.2217\/nnm.16.3","journal-title":"Nanomedicine (Lond)"},{"key":"ref139","doi-asserted-by":"publisher","DOI":"10.1016\/j.snb.2018.11.074","article-title":"Point of care upconversion nanoparticles-based lateral flow assay quantifying myoglobin in clinical human blood samples","volume":"282","author":"Ji T","year":"2019","unstructured":"Ji T, Xu X, Wang X, et al.. Point of care upconversion nanoparticles-based lateral flow assay quantifying myoglobin in clinical human blood samples. Sens Actuators B: Chem. 2019, 282:309-16. 10.1016\/j.snb.2018.11.074","journal-title":"Sens Actuators B: Chem"},{"key":"ref140","doi-asserted-by":"publisher","DOI":"10.3390\/nano6070133","article-title":"Nanomaterials for cardiac myocyte tissue engineering","volume":"6","author":"Amezcua R","year":"2016","unstructured":"Amezcua R, Shirolkar A, Fraze C, Stout DA. Nanomaterials for cardiac myocyte tissue engineering. Nanomaterials (Basel). 2016, 6:133. 10.3390\/nano6070133","journal-title":"Nanomaterials (Basel)"},{"key":"ref141","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241814233","article-title":"Evolution of CRISPR\/Cas systems for precise genome editing","volume":"24","author":"Hryhorowicz M","year":"2023","unstructured":"Hryhorowicz M, Lipi\u0144ski D, Zeyland J. Evolution of CRISPR\/Cas systems for precise genome editing. Int J Mol Sci. 2023, 24:14233. 10.3390\/ijms241814233","journal-title":"Int J Mol Sci"},{"key":"ref142","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-genom-120122-081037","article-title":"Sickle cell disease: From genetics to curative approaches","volume":"24","author":"Hardouin G","year":"2023","unstructured":"Hardouin G, Magrin E, Corsia A, Cavazzana M, Miccio A, Semeraro M. Sickle cell disease: From genetics to curative approaches. Annu Rev Genomics Hum Genet. 2023, 24:255-75. 10.1146\/annurev-genom-120122-081037","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"ref143","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.01.019","article-title":"Blocking HbS polymerization in SCD","volume":"180","author":"Lettre G","year":"2020","unstructured":"Lettre G. Blocking HbS polymerization in SCD. Cell. 2020, 180:819. 10.1016\/j.cell.2020.01.019","journal-title":"Cell"},{"key":"ref144","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2018.12.003","article-title":"AAAPT diagnostic criteria for acute sickle cell disease pain","volume":"20","author":"Field JJ","year":"2019","unstructured":"Field JJ, Ballas SK, Campbell CM, et al.. AAAPT diagnostic criteria for acute sickle cell disease pain. J Pain. 2019, 20:746-59. 10.1016\/j.jpain.2018.12.003","journal-title":"J Pain"},{"key":"ref145","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2024-066842","article-title":"Health supervision for children and adolescents with sickle cell disease: clinical report","volume":"154","author":"Yates AM","year":"2024","unstructured":"Yates AM, Aygun B, Nuss R, Rogers ZR. Health supervision for children and adolescents with sickle cell disease: clinical report. Pediatrics. 2024, 154:10.1542\/peds.2024-066842","journal-title":"Pediatrics"},{"key":"ref146","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-031-84988-6_10","article-title":"Hematopoietic stem cell transplantation in sickle cell disease","volume":"1475","author":"Essa M","year":"2025","unstructured":"Essa M, Alzahrani M, Alahmari AD, Aljurf M. Hematopoietic stem cell transplantation in sickle cell disease. Adv Exp Med Biol. 2025, 1475:177-91. 10.1007\/978-3-031-84988-6_10","journal-title":"Adv Exp Med Biol"},{"key":"ref147","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2025.03.016","article-title":"Current and future treatments for sickle cell disease: from hematopoietic stem cell transplantation to in vivo gene therapy","volume":"33","author":"Ball J","year":"2025","unstructured":"Ball J, Bradley A, Le A, Tisdale JF, Uchida N. Current and future treatments for sickle cell disease: from hematopoietic stem cell transplantation to in vivo gene therapy. Mol Ther. 2025, 33:2172-91. 10.1016\/j.ymthe.2025.03.016","journal-title":"Mol Ther"},{"key":"ref148","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2021.09.010","article-title":"CRISPR-Cas9 to induce fetal hemoglobin for the treatment of sickle cell disease","volume":"23","author":"Demirci S","year":"2021","unstructured":"Demirci S, Leonard A, Essawi K, Tisdale JF. CRISPR-Cas9 to induce fetal hemoglobin for the treatment of sickle cell disease. Mol Ther Methods Clin Dev. 2021, 23:276-85. 10.1016\/j.omtm.2021.09.010","journal-title":"Mol Ther Methods Clin Dev"},{"key":"ref149","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1705342","article-title":"Gene therapy in patients with transfusion-dependent \u03b2-thalassemia","volume":"378","author":"Thompson AA","year":"2018","unstructured":"Thompson AA, Walters MC, Kwiatkowski J, et al.. Gene therapy in patients with transfusion-dependent \u03b2-thalassemia. N Engl J Med. 2018, 378:1479-93. 10.1056\/NEJMoa1705342","journal-title":"N Engl J Med"},{"key":"ref150","doi-asserted-by":"publisher","DOI":"10.1017\/erm.2025.10","article-title":"Advancing CRISPR genome editing into gene therapy clinical trials: progress and future prospects","volume":"27","author":"Cetin B","year":"2025","unstructured":"Cetin B, Erendor F, Eksi YE, Sanlioglu AD, Sanlioglu S. Advancing CRISPR genome editing into gene therapy clinical trials: progress and future prospects. Expert Rev Mol Med. 2025, 27:e16. 10.1017\/erm.2025.10","journal-title":"Expert Rev Mol Med"},{"key":"ref151","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-36506-w","article-title":"Effective CRISPR\/Cas9-mediated correction of a Fanconi anemia defect by error-prone end joining or templated repair","volume":"9","author":"van de Vrugt HJ","year":"2019","unstructured":"van de Vrugt HJ, Harmsen T, Riepsaame J, et al.. Effective CRISPR\/Cas9-mediated correction of a Fanconi anemia defect by error-prone end joining or templated repair. Sci Rep. 2019, 9:768. 10.1038\/s41598-018-36506-w","journal-title":"Sci Rep"},{"key":"ref152","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-022-02462-9","article-title":"Fanconi anemia: current insights regarding epidemiology, cancer, and DNA repair","volume":"141","author":"Peake JD","year":"2022","unstructured":"Peake JD, Noguchi E. Fanconi anemia: current insights regarding epidemiology, cancer, and DNA repair. Hum Genet. 2022, 141:1811-36. 10.1007\/s00439-022-02462-9","journal-title":"Hum Genet"},{"key":"ref153","doi-asserted-by":"publisher","DOI":"10.3390\/genes11040466","article-title":"Base editing: the ever expanding clustered regularly interspaced short palindromic repeats (CRISPR) tool kit for precise genome editing in plants","volume":"11","author":"Monsur MB","year":"2020","unstructured":"Monsur MB, Shao G, Lv Y, Ahmad S, Wei X, Hu P, Tang S. Base editing: the ever expanding clustered regularly interspaced short palindromic repeats (CRISPR) tool kit for precise genome editing in plants. Genes (Basel). 2020, 11:466. 10.3390\/genes11040466","journal-title":"Genes (Basel)"},{"key":"ref154","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2020.07.021","article-title":"Current status and challenges of DNA base editing tools","volume":"28","author":"Jeong YK","year":"2020","unstructured":"Jeong YK, Song B, Bae S. Current status and challenges of DNA base editing tools. Mol Ther. 2020, 28:1938-52. 10.1016\/j.ymthe.2020.07.021","journal-title":"Mol Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/357589-reactive-oxygen-species-in-cardiovascular-and-hematological-diseases-mechanisms-and-therapeutic-strategies","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T04:51:30Z","timestamp":1787892690000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/357589-reactive-oxygen-species-in-cardiovascular-and-hematological-diseases-mechanisms-and-therapeutic-strategies"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":154,"URL":"https:\/\/doi.org\/10.7759\/cureus.115330","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,27]]}}}